The purpose of this legislation is to classify a specific group of opioids known as 2-benzylbenzimidazole opioids, commonly referred to as nitazenes, as Schedule 1 controlled substances. This classification is intended to strengthen the legal framework for regulating these substances, which are considered dangerous and have been linked to increased risks of overdose and addiction. Key provisions of the legislation include the permanent scheduling of nitazenes under the Controlled Substances Act.